Lung cancer trials in China

In China 1144 Also abroad 2746

1,144 trials · From ClinicalTrials.gov, checked 14 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
Immune Treatment of Brain Metastasis of Lung Cancer Combined With Large-segmentation Precision Radiotherapy
Where
Changsha
Age
18 years and over
People
140
Run by
Hunan Province Tumor Hospital
See details and how to joinNCT05584267
Phase 1/2Taking people
The Efficacy and Safety of LMV-12 Combined With Osimertinib in NSCLC
Where
Changsha
Age
18 years and over
People
120
Run by
Hunan Province Tumor Hospital
See details and how to joinNCT06109558
Phase 2Taking people
Neoadjuvant Therapy With Toripalimab and JS004 Combined With Etoposide and Platinum Chemotherapy for Limited-stage Small Cell Lung Cancer : A Phase 2 Trial
Where
Shanghai
Age
18 years and over
People
30
Run by
Shanghai Pulmonary Hospital, Shanghai, China
See details and how to joinNCT06256237
No phaseTaking people
a Single-arm, Single-center, Open Clinical Study
Where
Zhengzhou
Age
18 years to 75 years
People
10
Run by
Beijing Geekgene Technology Co., LTD
See details and how to joinNCT06431100
Phase 2Taking people
A Study Comparing Neoadjuvant Chemoimmunotherapy and Immuno-consolidationafter Compared With Immunoconsolidation After Radical Chemoradiotherapy for Stage III Potentially Resectable NSCLC
Where
Hangzhou
Age
18 years to 75 years
People
92
Run by
Zeng Jian
See details and how to joinNCT06424899
No phaseNot yet taking people in China
A Prospective Interventional Study on Early Screening for Lung Cancer Using Liquid Biopsy
Where
Guangzhou
Age
40 years to 75 years
People
5,944
Run by
The First Affiliated Hospital of Guangzhou Medical University
See details and how to joinNCT06422637
Phase 2Taking people
A Prospective, Single-arm, Phase II Clinical Trial to Evaluate the Efficacy and Safety of Tafolecimab and Sintilimab Combined With Chemotherapy in Patients With Advanced or Metastatic Driver Gene-negative Non-small Cell Lung Cancer After Failure of First-line Immunotherapy.
Where
Beijing
Age
18 years to 75 years
People
30
Run by
Jinghui Wang
See details and how to joinNCT06421298
Phase 3Not yet taking people in China
Clinical Study of 18F-Alfatide Injection PET/CT
Where
Wuhan
Age
18 years and over
People
428
Run by
Yantai LNC Biotechnology Singapore PTE. LTD.
See details and how to joinNCT06416852
No phaseTaking people
Observation on the Therapeutic Effect of Huaier Granules in the Adjuvant Treatment of Non-small Cell Lung Cancer After Radical Surgery
Where
Shenyang
Age
18 years to 75 years
People
240
Run by
Liaoning Cancer Hospital & Institute
See details and how to joinNCT06109454
Phase 2Taking people
Neoadjuvant Targeted Therapy in Patients With Resectable EGFR-mutated Lung Squamous Cell Carcinoma
Where
Guangzhou
Age
18 years to 75 years
People
51
Run by
The First Affiliated Hospital of Guangzhou Medical University
See details and how to joinNCT06383728
Phase 1Taking people
A Phase I Clinical Study of QLC1101 in Patients With Advanced Solid Tumors
Where
Guangzhou, Harbin, Kunming, Nanchang, Shanghai
Age
18 years and over
People
250
Run by
Qilu Pharmaceutical Co., Ltd.
See details and how to joinNCT06403735
No phaseTaking people
Pulmonary Watershed Topographic Map Navigation for Lung Nodule Resection
Where
Guangzhou
People
3,000
Run by
Guangdong Provincial People's Hospital
See details and how to joinNCT06404164
No phaseTaking people
Efficacy and Safety of Intraventricule Pemetrexed Disodium Administered Via Ommaya Reservoir
Where
Changsha
Age
18 years and over
People
64
Run by
Xiangya Hospital of Central South University
See details and how to joinNCT06399926
Phase 3Taking people
D-1553 Tablet Versus Docetaxel Injection for KRAS G12C Mutation-positive Locally Advanced or Metastatic Non-small Cell Lung Cancer After Prior Standard Therapy Failure
Where
Anyang, Baoding, Beijing, Changchun, Changsha, Changzhi, Changzhou, Chengde, Chengdu, Chongqing, Fuzhou, Guangzhou, Guilin, Guiyang, Haikou, Hangzhou, Harbin, Hefei, Jiamusi, Jinan, Jining, Kunming, Lanzhou, Luoyang, Luzhou, Mianyang, Nanchang, Nanjing, Nanning, Nantong, Nanyang, Neijiang, Qingdao, Shanghai, Shenyang, Shijiazhuang, Tai’an, Taiyuan, Tangshan, Tianjin, Ürümqi, Weifang, Weihai, Wenzhou, Wuhan, Wuxi, Xiamen, Xi’an, Xian, Xinxiang, Xuchang, Xuzhou, Yulin, Zhanjiang, Zhengzhou, Zunyi
Age
18 years and over
People
522
Run by
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
See details and how to joinNCT06300177
No phaseTaking people
Neuroendocrine Transformation in RB1/TP53 Inactivated NSCLC
Where
Shanghai
Age
18 years and over
People
50
Run by
Fudan University
See details and how to joinNCT06369181
Phase 1Taking people
A Randomised Trial of Chemotherapy Plus Surgery for Recurrent Non-Small Cell Lung Cancer
Where
Changchun, Shanghai
Age
18 years to 75 years
People
500
Run by
Shanghai Jiao Tong University School of Medicine
See details and how to joinNCT02889666
Phase 2Taking people
Osimertinib Plus Dalpiciclib in Patients With EGFR-mutant, CDK4/6 Pathway Aberrant, Advanced Non-small Cell Lung Cancer Following Acquired Resistance to Third-generation EGFR TKI: a Phase II Trial
Where
Tianjin
Age
18 years to 75 years
People
32
Run by
Tianjin Medical University Cancer Institute and Hospital
See details and how to joinNCT06363734
No phaseTaking people
Real World Study of Lolatinib for Advanced ALK+ NSCLC Patients
Where
Chengdu
Age
18 years and over
People
200
Run by
Sichuan Cancer Hospital and Research Institute
See details and how to joinNCT06361589
Phase 3Taking people
Survival With Olanzapine in Patients With Locally Advanced or Metastatic Upper Gastrointestinal and Lung Cancer
Where
Xining
Age
18 years to 80 years
People
230
Run by
Qinghai Red Cross Hospital
See details and how to joinNCT06338683
Phase 2/3Not yet taking people in China
A Phase II/III Study of Adebrelimab in Combination With SHR-8068 and Chemotherapy in Advanced or Metastatic NSCLC Patients
Where
Jinan
Age
18 years to 75 years
People
401
Run by
Shanghai Shengdi Pharmaceutical Co., Ltd
See details and how to joinNCT06335355
Phase 1/2Not yet taking people in China
Safety and Efficacy of Adebrelimab Plus Irinotecan Liposome (II) With or Without Famitinib in ES-SCLC Pre-treated With Immunotherapy
Where
Shanghai
Age
18 years to 75 years
People
80
Run by
Baohui Han
See details and how to joinNCT06332950
No phaseTaking people
Assessment System of Sarcopenia in Lung Cancer Patients
Where
Chengdu
Age
40 years to 100 years
People
1,500
Run by
West China Hospital
See details and how to joinNCT06327594
No phaseTaking people
Omitting CTV for Locally Advanced NSCLC Responded to Immunotherapy and Chemotherapy
Where
Wuhan
Age
18 years to 75 years
People
134
Run by
Hubei Cancer Hospital
See details and how to joinNCT06020430
Phase 2Taking people
Single-drug Chemotherapy Plus Immunotherapy in Metastatic Non-small Cell Lung Cancer Elderly Patients
Where
Wuhan
Age
65 years and over
People
49
Run by
Hubei Cancer Hospital
See details and how to joinNCT06032052
No phaseTaking people
Primary Tumor Radiotherapy Omitting CTV for Patients With Advanced NSCLC Responded to Immunotherapy and Chemotherapy
Where
Wuhan
Age
18 years to 75 years
People
134
Run by
Hubei Cancer Hospital
See details and how to joinNCT06037733